Evaluation of a vaccination campaign with A(H1N1)v pandemic vaccines: a prospective cohort study.A(H1N1)v-pandemiarokotuskampanjan vaikutukset - Pandemiarokotuskampanjatutkimus

ational Institute for Health and Welfare0 个研究点目标入组 4,000 人开始时间: 2009年9月29日最近更新: 2015年1月6日

试验速览

暂无简介。

•Full legal competence;
•Written informed consent obtained;
•Assigned to use the services of Tampere health centre and community-dwelling;
•At least 18 and no more than 75 years old, inclusive;
•Belongs to the target group of A(H1N1)v vaccination in the region during the pandemic vaccination campaign;
•Able to communicate fluently in Finnish or Swedish
•Able to adhere to all protocol required study procedures without any special burden or risk, as judged by the investigator or designate.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•For the total study cohort, no specific exclusion criteria will be applied;
•For the subgroup for follow-up of immunogenicity of the vaccine (immunogenicity cohort), exclusion criteria comprise:
•oprevious severe allergic reaction to influenza vaccines or known severe allergy to the ingredients of the vaccine
•oprevious severe allergic reaction to eggs
•osignificant immunological disorder

发起方

ational Institute for Health and Welfare